Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Market Correction in 2018? Hedge Funds Say You Should Own These 5 Stocks

After a 2017 that was one of the least volatile years on the stock market in decades, 2018 looks primed to make up for that lack of spunk and then some. Volatility as measured by the VIX index has jumped considerably in the last week as rumblings of a large market correction began picking up steam and that resulted in a massive selloff starting last Friday that saw the S&P lose nearly 200 points in two trading days, while the Dow lost nearly 2,000 points.

While Wells Fargo believes the worst is already behind us and that stocks could rebound by 10% throughout the rest of the year, other pundits are calling for yet more declines and as much as a 15-20% correction in 2018. In this article, we’ll look at five stocks that are beloved by the most successful hedge funds in the world, and which could be promising picks to outperform the market in 2018 should a notable correction indeed be in the cards for the U.S stock market.

At Insider Monkey, we track insider trading and hedge fund activity to uncover actionable patterns and profit from them. We track over 600 of the most successful hedge funds ever in our database and identify only their best stock picks. Hedge funds are like many other companies in that they bundle products (in this case, stock picks) together and sell them to customers (investors) as a package deal. That means you get their 73rd-best pick along with their best pick, and who wants to pay exorbitant fees for a fund’s 73rd-best idea when you could instead invest in only their best ideas? Our newest stock picks will be released later this month, which investors can gain access to by becoming a subscriber to Insider Monkey’s premium newsletters.

mcdonald, mc, donalds, thailand, corporation, million, business, symbol, serving, people, eat, hamburger, design, food, daily, red, restaurant, chain, junk, brasov,

saknakorn / Shutterstock.com

McDonald’s Corporation (NYSE:MCD)

McDonald’s Corporation (NYSE:MCD) was one of the few stocks that didn’t get battered during the 2008 financial crisis, posting gains of 9% while the broader market lost over half of its value. McDonald’s is capable of having the same type of growth spurt today should tough market conditions persist thanks to its revamped value menu, which reports indicate has been very popular since launch. McDonald’s has pulled back by 10% during the past week, creating a promising entry point for buyers.

McDonald’s Corporation (NYSE:MCD) was owned by 60 of the hedge funds that Insider Monkey tracks on September 30, an increase from 57 three months earlier. It was also owned by nine billionaire investors, including Ken Griffin, a self-professed lover of McDonald’s. Griffin’s firm, Citadel Investment Management, owned 2.62 million McDonald’s Corporation (NYSE:MCD) shares on September 30.

Follow Mcdonalds Corp (NYSE:MCD)
Trade (NYSE:MCD) Now!

Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) has an enviable stable of consumer goods products and OTC and prescription drugs, including Tylenol, Sudafed, Nicorette, Aveeno, Darzalex, and Imbruvica. Johnson & Johnson is also one of the most reliable dividend stocks one can find, with the company having raised its dividend for over 50 years running, through markets good and bad. Johnson & Johnson (NYSE:JNJ) was owned by 75 hedge funds in our system at the end of September, ranking it as the 26th-most popular stock among them.

Johnson & Johnson (NYSE:JNJ) shares are down by 15% over the past two weeks, creating an intriguing buying opportunity, as investors have worried over the potential damages that could result from a lawsuit filed against the company that alleges that it knowingly sold baby powder which contained asbestos fibers. A California woman was awarded $417 million last year in a lawsuit against Johnson & Johnson which alleged that she got ovarian cancer due to using talcum powder for 50 years. The award was later thrown out. Even should Johnson & Johnson not be as fortunate in the newest case, analysts believe any potential damages would be manageable for the company.

Follow Johnson & Johnson (NYSE:JNJ)
Trade (NYSE:JNJ) Now!

On the next page we’ll look at three more stocks hedgies like that could outperform the market should there be a correction in 2018.

Loading...